Noninferiority of Telemedicine Delivered Compared With In-person Diabetes Self-Management Education and Support (DSMES) During Covid-19 Pandemic in Thailand
Issued Date
2022-11-01
Resource Type
ISSN
10105395
eISSN
19412479
Scopus ID
2-s2.0-85138336115
Pubmed ID
36124368
Journal Title
Asia-Pacific Journal of Public Health
Volume
34
Issue
8
Start Page
799
End Page
803
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asia-Pacific Journal of Public Health Vol.34 No.8 (2022) , 799-803
Suggested Citation
Areevut C., Sakmanarit J., Tachanivate P., Jerawatana R., Vittayakasemsont K., Pookate W., Kamnirdsittiseree P., Savetkairop B., Saibuathong N., Chanchat S. Noninferiority of Telemedicine Delivered Compared With In-person Diabetes Self-Management Education and Support (DSMES) During Covid-19 Pandemic in Thailand. Asia-Pacific Journal of Public Health Vol.34 No.8 (2022) , 799-803. 803. doi:10.1177/10105395221126010 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/85427
Title
Noninferiority of Telemedicine Delivered Compared With In-person Diabetes Self-Management Education and Support (DSMES) During Covid-19 Pandemic in Thailand
Author's Affiliation
Other Contributor(s)
Abstract
This study aimed to compare the clinical outcomes and program satisfaction of diabetes self-management education and support (DSMES) for type 2 diabetes patients delivered by telehealth during COVID-19 pandemic to in-person delivery during pre-COVID-19. A retrospective case-controlled study was conducted (95 telehealth and 95 on-site). Differences in hemoglobin A1c (HbA1c) reductions between groups were analyzed by linear mixed-effects models, and satisfaction was collected. Compared with baseline, at the three-month follow-up, the HbA1c reductions of the telehealth and on-site DSMES were 1.20 ± 0.15% and 1.21 ± 0.15%, respectively (P <.001), whereas these were 1.28 ± 0.16% and 1.18 ± 0.15% at six-month follow-up, respectively (P <.001). There were no significant differences in HbA1c reduction between the two groups (P =.967 and.674 at three- and six-month follow-up). Majority of participants in both groups had high program satisfaction (telehealth 98.7% vs on-site 95.1%, P =.269). In conclusion, DSMES delivered via telehealth is as effective in lowering HbA1c as that delivered in-person, with a high satisfaction rate.